LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $212.45M |
| Net Income (Most Recent Fiscal Year) | $-18.88M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.32 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -1.83% |
| Net Margin (Trailing 12 Months) | -2.41% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -8.11% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.77 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 9.21 |
| Inventory Turnover (Trailing 12 Months) | 10.47 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.09 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.06 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.53 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.21 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 47.42M |
| Free Float | 38.69M |
| Market Capitalization | $323.39M |
| Average Volume (Last 20 Days) | 2.32M |
| Beta (Past 60 Months) | 1.72 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 18.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 35.52% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |